Results 101 to 110 of about 19,943,678 (222)
Nigerian Journal of Medicine, 2020 Background: Since the approval of warfarin, a Vitamin K antagonist anticoagulant (VKA), no other oral anticoagulant existed for patients who needed long‑term anticoagulation therapy until the recent introduction of non‑VKA oral anticoagulants (NOACs). NOACs came to fill in therapeutic gaps associated with VKA.
openaire +3 more sources
Osteoporosis and Periodontitis: Two‐Way Epidemiological and Mechanistic Evidence
Journal of Periodontal Research, EarlyView.This review investigates the main mechanistic pathways connecting local periodontitis to systemic osteoporosis. Seven interconnected mechanisms are identified. ABSTRACT Osteoporosis and periodontitis are highly prevalent, chronic inflammatory diseases that constitute a major global health burden.
Jia Chang +3 more
wiley +1 more source
Oral Diseases, EarlyView.ABSTRACT Background Direct oral anticoagulants (DOACs) are the first‐line therapy for stroke prevention in non‐valvular atrial fibrillation and venous thromboembolism. While evidence supports their continuation during routine dental procedures such as tooth extractions, data on oral soft tissue biopsies remain limited.
Rossana Izzetti +3 more
wiley +1 more source
Pharmacological profile of non-vitamin K antagonist oral anticoagulants [PDF]
African Journal of Pharmacy and Pharmacology, 2017 The non-vitamin K antagonist oral anticoagulants have been approved since 2008 for the prevention of systemic embolism and stroke in patients with non-valvular atrial fibrillation with prior stroke, transient ischemic attack, or CHA2DS2-VASc score ≥2.
openaire +1 more source
Oral Diseases, EarlyView.ABSTRACT Objective This narrative review critically assesses the clinical relevance of pharmacogenomics within dental genomics, distinguishing clinically actionable applications from emerging or investigational findings. Materials and Methods A targeted literature review was conducted in PubMed/MEDLINE, Scopus and Embase for publications from January ...
Giorgia Pieretto +3 more
wiley +1 more source
Introduction: Few real-world studies have investigated drug-drug interactions (DDIs) involving non-vitamin-K antagonist oral anticoagulants (NOACs) in patients with nonvalvular atrial fibrillation (NVAF).
Jann-Yuan Wang +8 more
core +1 more source
Intracranial hemorrhage in patients taking oral anticoagulants. Current possibilities for therapy
Неврология, нейропсихиатрия, психосоматика, 2019 The paper reviews an update on the possibilities of providing care for patients with spontaneous non-traumatic intracranial hemorrhage (ICH) developing in patients with atrial fibrillation who use oral anticoagulants.
S. N. Yanishevsky
doaj +1 more source
Impact of Leadless Pacemaker Implantation Position on Subclinical Right Ventricular Perforation
Pacing and Clinical Electrophysiology, EarlyView.ABSTRACT Introduction Leadless pacemakers are typically implanted in the mid‐septum of the right ventricle (RV) to mitigate the risk of perforation. However, reports on the precise location of these implants are limited. This study aimed to elucidate tine‐based leadless pacemaker position and presence of subclinical RV perforation through computed ...
Young Shin Lee +16 more
wiley +1 more source
Management of Left Atrial Appendage Thrombi and Spontaneous Echo Contrast
Pacing and Clinical Electrophysiology, EarlyView.ABSTRACT Background To analyze the efficacy and safety of various anticoagulation strategies/regimen used for managing thrombus or spontaneous echo contrast in the left atrial appendage. Methods Thrombus or spontaneous echo contrast in the left atrial appendage was detected via transesophageal echocardiography in 83 patients, most often during a stroke
Timnou Bekouti Jean +10 more
wiley +1 more source
Медицинский совет, 2014 The article tells about prevention of ischemic stroke (IS) in patients after IS or transient ischemic attack (TIA) against a background of non-valvular atrial fibrillation (AF).
V. A. Parfyonov, S. V. Verbitskaya
doaj +1 more source